Kiora Pharmaceuticals, Inc. (KPRX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD

Add to watchlist

0.5459

+0.0009

(+0.17%)

At close: 04:00PM EDT

0.5458

-0.00

(-0.02%)

After hours:

04:38PM EDT

Major holders

Insider roster

Insider transactions

Currency in USD

Insider purchases - Last 6 months	Shares	Trans
Purchases	0	0
Sales	N/A	0
Net shares purchased (sold)	0	0
Total insider shares held	226.33k	N/A
% net shares purchased (sold)	N/A	N/A

Net institutional purchases - Prior quarter to latest quarter	Shares
Net shares purchased (sold)	N/A
% change in institutional shares held	N/A

Insider transactions reported - last two years

Insider	Transaction	Type	Value	Date	Shares
STREM BRIAN M. Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	29 Sept 2023	75,000
DANIELS ERIC JOSEPH Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	29 Sept 2023	62,500
TOSCA MELISSA Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	29 Sept 2023	30,000
STREM BRIAN M. Chief Executive Officer	Stock Award(Grant) at price 3.83 per share.	Direct	59,748	03 Mar 2023	15,600
DANIELS ERIC JOSEPH Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	03 Mar 2023	15,600
TOSCA MELISSA Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	03 Mar 2023	2,400
STREM BRIAN M. Chief Executive Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	21 Oct 2022	12,500
DANIELS ERIC JOSEPH Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	21 Oct 2022	10,000
TOSCA MELISSA Officer	Stock Award(Grant) at price 0.00 per share.	Direct	0	21 Oct 2022	2,500
STREM BRIAN M. Chief Executive Officer	Purchase at price 1.41 per share.	Direct	25,173	18 Nov 2021	17,853
STREM BRIAN M. Chief Executive Officer		Direct		21 Oct 2021	9,517
DANIELS ERIC JOSEPH Officer		Direct		21 Oct 2021	9,520
ARMISTICE CAPITAL L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 2.40 - 2.69 per share.	Indirect	646,608	02 Aug 2021	260,963
ARMISTICE CAPITAL L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 3.00 - 7.06 per share.	Indirect	14,546,264	29 Jul 2021	3,153,138
ARMISTICE CAPITAL L.L.C. Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 4.80 per share.	Indirect	4,092,000	27 Jul 2021	852,500
ARMISTICE CAPITAL L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 5.22 per share.	Indirect	8,000,003	06 Jan 2021	1,531,101
FROM STEPHEN Chief Executive Officer		Direct		14 Feb 2020	20,000
MANZO MICHAEL P Officer		Direct		14 Feb 2020	7,500
MANN BRENDA Officer		Direct		14 Feb 2020	7,500
ROMANO SARAH M. Chief Financial Officer		Direct		14 Feb 2020	10,000
ARMISTICE CAPITAL L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 6.04 - 6.18 per share.	Indirect	140,460	10 Feb 2020	23,000
GOLDBERG MORTON Director	Sale at price 6.93 per share.	Direct	13,590	06 Dec 2019	1,961
GOLDBERG MORTON Director	Sale at price 4.29 per share.	Direct	8,584	12 Nov 2019	2,001
ARMISTICE CAPITAL L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.11 - 3.17 per share.	Indirect	1,890,613	30 Sept 2019	605,001
FROM STEPHEN Chief Executive Officer	Sale at price 0.23 - 0.24 per share.	Direct	30,107	15 Jul 2019	127,355
MANZO MICHAEL P Officer	Sale at price 0.23 - 0.24 per share.	Direct	4,669	15 Jul 2019	19,750
MANN BRENDA Officer	Sale at price 0.23 - 0.24 per share.	Direct	4,503	15 Jul 2019	19,049
WIROSTKO BARBARA M.D. Officer	Sale at price 0.23 - 0.24 per share.	Direct	4,601	15 Jul 2019	19,463
ROMANO SARAH M. Chief Financial Officer	Sale at price 0.23 - 0.24 per share.	Direct	4,669	15 Jul 2019	19,750
ARMISTICE CAPITAL L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 0.31 - 0.35 per share.	Indirect	175,216	29 Mar 2019	549,647
ARMISTICE CAPITAL L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 0.39 - 0.42 per share.	Indirect	40,316	11 Dec 2018	100,353
ARMISTICE CAPITAL L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 0.41 - 0.47 per share.	Indirect	161,395	16 Nov 2018	360,000
TYLE PRAVEEN Director		Direct		10 Jul 2018	50,000
CHANEY PAUL G Director		Direct		10 Jul 2018	50,000
FROM STEPHEN Chief Executive Officer		Direct		10 Jul 2018	750,000
GOLDBERG MORTON Director		Direct		10 Jul 2018	50,000
MANZO MICHAEL P Officer		Direct		10 Jul 2018	175,000
MANN BRENDA Officer		Direct		10 Jul 2018	175,000
WIROSTKO BARBARA M.D. Officer		Direct		10 Jul 2018	175,000
ROMANO SARAH M. Chief Financial Officer		Direct		10 Jul 2018	175,000
MALFROY-CAMINE BERNARD Director		Direct		10 Jul 2018	50,000
GARANZINI MICHAEL Officer		Direct		10 Jul 2018	25,000
WIROSTKO BARBARA M.D. Officer	Stock Award(Grant) at price 0.52 - 0.54 per share.	Direct	4,932	08 Jun 2018	9,215
WIROSTKO BARBARA M.D. Officer	Stock Award(Grant) at price 0.52 - 0.54 per share.	Indirect	9,924	08 Jun 2018	18,815
ARMISTICE CAPITAL L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 0.57 - 0.58 per share.	Indirect	33,433	29 May 2018	58,275
ARMISTICE CAPITAL L.L.C. Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 0.56 per share.	Indirect	959	18 May 2018	1,725
ARMISTICE CAPITAL L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 0.53 - 0.54 per share.	Indirect	8,417	14 May 2018	15,758
ARMISTICE CAPITAL L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 0.50 - 0.54 per share.	Indirect	90,992	11 May 2018	177,012
ARMISTICE CAPITAL L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 0.45 - 0.49 per share.	Indirect	63,472	08 May 2018	137,230
ARMISTICE CAPITAL L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 0.54 per share.	Indirect	89,266	26 Apr 2018	165,522
ARMISTICE CAPITAL L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 0.47 - 0.53 per share.	Indirect	1,231,159	20 Apr 2018	2,534,478
FROM STEPHEN Chief Executive Officer		Direct		17 Apr 2018	125,000
ROMANO SARAH M. Chief Financial Officer		Direct		17 Apr 2018	62,500
ARMISTICE CAPITAL L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 0.33 - 0.44 per share.	Indirect	3,740,050	17 Apr 2018	10,479,970
GARANZINI MICHAEL Officer		Direct		17 Apr 2018	156,250
GARANZINI MICHAEL Officer	Stock Award(Grant) at price 1.07 per share.	Direct	16,050	17 Nov 2017	15,000
WIROSTKO BARBARA M.D. Officer	Stock Award(Grant) at price 1.20 - 1.23 per share.	Indirect	23,334	15 Sept 2017	19,200
ROMANO SARAH M. Chief Financial Officer	Purchase at price 1.00 per share.	Direct	10,000	15 Aug 2017	10,000
FROM STEPHEN Chief Executive Officer	Purchase at price 1.03 per share.	Direct	12,875	10 Aug 2017	12,500
FROM STEPHEN Chief Executive Officer		Direct		14 Jun 2017	60,000
ROMANO SARAH M. Chief Financial Officer		Direct		14 Jun 2017	20,000
CHANEY PAUL G Director	Conversion of Exercise of derivative security at price 0.65 per share.	Direct	11,420	02 Jun 2017	17,570
MANZO MICHAEL P Officer	Conversion of Exercise of derivative security at price 0.65 per share.	Direct	4,735	15 May 2017	7,285
VENTECH CAPITAL II Beneficial Owner of more than 10% of a Class of Security	Sale at price 2.80 per share.	Direct	12,385	13 Mar 2017	4,419
WIROSTKO BARBARA M.D. Officer	Stock Award(Grant) at price 2.83 per share.	Direct	24,621	07 Mar 2017	8,700
GOLDBERG MORTON Director	Sale at price 3.00 per share.	Direct	26,757	06 Mar 2017	8,919
WIROSTKO BARBARA M.D. Officer	Stock Award(Grant) at price 2.59 - 2.60 per share.	Indirect	248,798	28 Feb 2017	95,900
GOLDBERG MORTON Director	Conversion of Exercise of derivative security at price 1.70 per share.	Direct	1,841	27 Feb 2017	1,083
FROM STEPHEN Chief Executive Officer		Direct		06 Feb 2017	60,000
MANN BRENDA Officer		Direct		06 Feb 2017	2,500
WIROSTKO BARBARA M.D. Officer		Direct		06 Feb 2017	15,000
SARAH ROMANO Chief Financial Officer		Direct		06 Feb 2017	2,500
FROM STEPHEN Chief Executive Officer	Purchase at price 1.49 per share.	Direct	22,338	15 Sept 2016	15,000
FROM STEPHEN Chief Executive Officer	Conversion of Exercise of derivative security at price 0.65 per share.	Direct	34,327	30 Jun 2016	52,990
GOLDBERG MORTON Director	Sale at price 3.16 per share.	Direct	47,361	15 Jun 2016	15,000
VENTECH CAPITAL II Beneficial Owner of more than 10% of a Class of Security	Sale at price 3.00 - 3.08 per share.	Direct	86,856	10 Jun 2016	28,600
VENTECH CAPITAL II Beneficial Owner of more than 10% of a Class of Security	Sale at price 3.20 - 3.27 per share.	Direct	95,424	08 Jun 2016	29,400
GOLDBERG MORTON Director	Sale at price 3.25 - 3.37 per share.	Direct	36,203	07 Jun 2016	10,939
GOLDBERG MORTON Director	Conversion of Exercise of derivative security at price 0.65 per share.	Direct	21,879	03 Jun 2016	33,775
TYLE PRAVEEN Director		Direct		28 Aug 2015	5,748
CHANEY PAUL G Director		Direct		28 Aug 2015	7,408
HANCOCK THOMAS EDWIN Director		Direct		28 Aug 2015	6,519
CHAOUI MOUNIA Director		Direct		28 Aug 2015	5,037
FROM STEPHEN Chief Executive Officer		Direct		28 Aug 2015	14,807
GOLDBERG MORTON Director		Direct		28 Aug 2015	4,563
BALLAND THOMAS Director		Direct		28 Aug 2015	5,037
MANZO MICHAEL P Officer		Direct		28 Aug 2015	5,926
MALFROY CAMINE BERNARD Director		Direct		28 Aug 2015	5,570
TYLE PRAVEEN Director		Direct		01 May 2015	11,893
CHANEY PAUL G Director		Direct		01 May 2015	15,326
HANCOCK THOMAS EDWIN Director		Direct		01 May 2015	13,487
CHAOUI MOUNIA Director		Direct		01 May 2015	10,422
FROM STEPHEN Chief Executive Officer		Direct		01 May 2015	30,635
GOLDBERG MORTON Director		Direct		01 May 2015	9,441
BALLAND THOMAS Director		Direct		01 May 2015	10,422
MANZO MICHAEL P Officer		Direct		01 May 2015	12,261
MALFROY CAMINE BERNARD Director		Direct		01 May 2015	11,525
CHANEY PAUL G Director	Purchase at price 6.00 per share.	Direct	49,998	19 Feb 2015	8,333
VENTECH CAPITAL II Beneficial Owner of more than 10% of a Class of Security	Purchase at price 6.00 per share.	Direct	616,662	19 Feb 2015	102,777
VENTECH CAPITAL II Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 4.20 per share.	Direct	1,013,334	19 Feb 2015	1,391,456
INNOVEN PARTENAIRES S.A. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 6.00 per share.	Indirect	2,200,002	19 Feb 2015	366,667
INNOVEN PARTENAIRES S.A. Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 4.20 per share.	Indirect	580,415	19 Feb 2015	1,093,812
NATIXIS PRIVATE EQUITY Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 4.20 per share.	Indirect	410,092	19 Feb 2015	674,205

NZX 5011,783.39-26.09(-0.22%)

NZD/USD0.6123+0.0021(+0.35%)

NZD/EUR0.5638+0.0000(+0.01%)

ALL ORDS7,999.20-83.90(-1.04%)

ASX 2007,727.60-84.20(-1.08%)

OIL77.80+0.93(+1.21%)

Kiora Pharmaceuticals, Inc. (KPRX)

Insider transactions

Insider transactions reported - last two years

NZX 50
11,783.39
-26.09(-0.22%)

NZD/USD
0.6123
+0.0021(+0.35%)

NZD/EUR
0.5638
+0.0000(+0.01%)

ALL ORDS
7,999.20
-83.90(-1.04%)

ASX 200
7,727.60
-84.20(-1.08%)

OIL
77.80
+0.93(+1.21%)